IDEAYA Biosciences (IDYA) Assets Average (2019 - 2026)
IDEAYA Biosciences (IDYA) posted Assets Average of $1.1 billion for Q1 2026, down 6.75% sequentially from $1.1 billion in Q4 2025, and down 3.82% YoY from $1.1 billion in Q1 2025.
IDEAYA Biosciences (IDYA) Assets Average (2019 - 2026) Analysis & Trends
IDEAYA Biosciences has reported Assets Average for 8 years, with the latest figure at $1.1 billion in Q1 2026.
- Quarterly Assets Average fell 3.82% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 3.82% YoY) and the FY2025 annual result came in at $1.1 billion, up 25.94% from the prior year.
- Assets Average declined to $1.1 billion in Q1 2026 per IDYA's latest filing, from $1.1 billion in the prior quarter.
- Over five years, Assets Average peaked at $1.2 billion in Q4 2024 and troughed at $348.4 million in Q2 2022.
- A 5-year average of $765.4 million and a median of $805.4 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2026: Assets Average surged 116.88% in 2024, then dropped 3.82% in 2026.
- Over 5 years, Assets Average stood at $399.4 million in 2022, then jumped by 47.99% to $591.1 million in 2023, then jumped by 99.95% to $1.2 billion in 2024, then decreased by 2.94% to $1.1 billion in 2025, then fell by 6.75% to $1.1 billion in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | IDEAYA Biosciences | 3.50 Bn | 2.67 Bn | - | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 Bn |
| Mar 31, 2026 | 1.07 Bn |
| Dec 31, 2025 | 1.15 Bn |
| Sep 30, 2025 | 1.11 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 1.11 Bn |
| Dec 31, 2024 | 1.18 Bn |
| Sep 30, 2024 | 1.11 Bn |
| Jun 30, 2024 | 967.60 Mn |
| Mar 31, 2024 | 805.42 Mn |
| Dec 31, 2023 | 591.13 Mn |
| Sep 30, 2023 | 530.25 Mn |
| Jun 30, 2023 | 446.15 Mn |
| Mar 31, 2023 | 376.36 Mn |
| Dec 31, 2022 | 399.44 Mn |
| Sep 30, 2022 | 374.46 Mn |
| Jun 30, 2022 | 348.44 Mn |
| Mar 31, 2022 | 370.11 Mn |
| Dec 31, 2021 | 390.40 Mn |
| Sep 30, 2021 | 363.92 Mn |